1. Distel M, Bluhmki E. Global analysis of safety of meloxicam, a new enolic acid derived non-steroidal anti-inflammatory agent. Rheumatol Europe 1995; 3 Abstract e259.
2. Colberg K, Hettich M, Sigmand R et al. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. Curr Med Res Opin 1996; 13: 363–77.